Jump to content

Byron Nash Renal Medullary Carcinoma Awareness Act of 2021 (H.R. 124; 117th Congress)

From Wikisource
(Redirected from H.R. 124 (117th Congress))

117th CONGRESS
1st Session

H.R. 124

To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have Sickle Cell Disease.

IN THE HOUSE OF REPRESENTATIVES

January 4, 2021

Mr. Green of Texas introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have Sickle Cell Disease.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

[edit]

This Act may be cited as the “Byron Nash Renal Medullary Carcinoma Awareness Act of 2021”.


Sec. 2. PROVIDING INCENTIVES FOR EDUCATION ON RISK OF RENAL MEDULLARY CARCINOMA TO INDIVIDUALS WITH SICKLE CELL DISEASE UNDER MEDICAID.

[edit]
(a) In General.—Section 1903(a)(3)(E)(ii) of the Social Security Act (42 U.S.C. 1396b(a)(3)(E)(ii)) is amended by inserting “, renal medullary carcinoma,” after “stroke” each place it appears.
(b) Effective Date.—The amendments made by subsection (a) shall apply with respect to items and services furnished on or after the date of the enactment of this Act.

This work is in the public domain in the United States because it is a work of the United States federal government (see 17 U.S.C. 105).

Public domainPublic domainfalsefalse